Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Laboratoires Cyclopharma SA

Request full access

Laboratoires Cyclopharma SA developing innovative molecular imaging solutions

Saint-Beauzire, FranceFounded 2000Biotech & Life Sciences

About Laboratoires Cyclopharma SA

Laboratoires Cyclopharma SA, founded in 2000, is a French pharmaceutical company specializing in molecular imaging solutions. The company develops, produces, and distributes radiopharmaceutical tracers for diagnostic imaging in oncology, neurology, and cardiology to healthcare professionals. These tracers are used with Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT) scans to visualize tumors and other pathologies, aiming to improve therapeutic efficacy and patient outcomes.

In December 2013, the DENOS Group, led by Olivier Carli, acquired a majority stake in Cyclopharma in a transaction exceeding €10 million. This strategic move was intended to finance the market entry of new radiopharmaceutical products and accelerate the company's international expansion. Following the acquisition, Carli, a serial entrepreneur in the MedTech and BioTech sectors, became president, leading an experienced management team from the pharmaceutical industry. Before the acquisition, Cyclopharma had raised funds from investors including Bpifrance, CDC Enterprises, Crédit Agricole, and Societe Generale Capital Partenaires.

A significant milestone occurred in April 2018 when Curium acquired Cyclopharma's French production facilities and commercial operations. This transaction integrated Cyclopharma's seven PET radiopharmacies in France into Curium's network, enhancing production capabilities and coverage across the country. The research and development programs, along with international development projects and the US division, were not part of the deal and were spun off into a new company named Zionexa, owned by the historical shareholder, DENOS Group. This new entity focuses on developing and commercializing innovative diagnostic and therapeutic solutions, such as EstroTep, a PET tracer for breast cancer diagnosis.

Source: Dealroom company data

At a glance

Outcome tier
Colt$25–100M revenue

Laboratoires Cyclopharma SA in the Saint-Beauzire ecosystem

Live from Dealroom

The Laboratoires Cyclopharma SA office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • iXO Private Equity
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇫🇷 France75%
🇲🇦 Morocco25%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Laboratoires Cyclopharma SA on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Laboratoires Cyclopharma SA on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.